We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Invest in IQVIA Holdings (IQV) Now
Read MoreHide Full Article
IQVIA Holdings Inc. (IQV - Free Report) has had an impressive run in the past three months. The company’s shares have gained 12.9%, outperforming the 10.8% rally of the Zacks S&P 500 composite.
Let’s take a look at some other factors that make the stock an attractive pick.
Solid Rank & VGM Score: IQVIA currently carries a Zacks Rank #2 (Buy) and has a VGM Score of B. Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment.
Northward Estimate Revisions: Four estimates for 2024 moved north in the past 60 days versus no southward revision, reflecting analysts’ confidence in the company. The Zacks Consensus Estimate for 2023 earnings has moved up slightly in the past 60 days.
Positive Earnings Surprise History: IQV has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in all the trailing four quarters, delivering an earnings surprise of 1.6%, on average.
Strong Growth Prospects: The Zacks Consensus Estimate for IQV’s 2024 earnings is pegged at $11.04, indicating 8.3% year-over-year growth. The stock’s long-term expected earnings per share growth rate is 8.7%.
Growth Factors: IQVIA’s combined offerings of research and development and commercial services have been helping it to develop trusted relationships, resulting in a diversified base of more than 10,000 clients in over 100 countries.
The company has a huge collection of healthcare information that encompasses more than one billion comprehensive, longitudinal, non-identified patient records across sales, prescription and promotional data, electronic medical records, medical claims, genomics and social media. This enormous treasure trove of information is a distinguishing asset and perhaps a big barrier to entry for competitors.
IQVIA has a consistent record of share repurchases. In 2022, 2021 and 2020, the company repurchased shares worth $1.17 billion, $406 million and $447 million, respectively. Such moves not only instill investors’ confidence but also positively impact earnings per share.
Other Stocks to Consider
Investors interested in the broader Zacks Business Service sector may consider the following other top-ranked stocks:
Gartner (IT - Free Report) : The Zacks Consensus Estimate for Gartner’s 2023 revenues indicates 7.9% growth from the year-ago figure. Its earnings are expected to decline 1.9% year over year. The company’s earnings beat the consensus estimate in each of the trailing four quarters, with the average surprise being 34.4%.
Broadridge Financial Solutions (BR - Free Report) : The Zacks Consensus Estimate for Broadridge’s fiscal 2024 revenues indicates 7.7% growth from the year-ago figure. Its earnings are expected to grow 10.1% year over year. The company beat the consensus estimate for earnings in three of the past four quarters and matched once, with the average surprise being 5.4%.
BR currently carries a Zacks Rank of 2.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why You Should Invest in IQVIA Holdings (IQV) Now
IQVIA Holdings Inc. (IQV - Free Report) has had an impressive run in the past three months. The company’s shares have gained 12.9%, outperforming the 10.8% rally of the Zacks S&P 500 composite.
Let’s take a look at some other factors that make the stock an attractive pick.
Solid Rank & VGM Score: IQVIA currently carries a Zacks Rank #2 (Buy) and has a VGM Score of B. Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment.
IQVIA Holdings Inc. Price
IQVIA Holdings Inc. price | IQVIA Holdings Inc. Quote
Northward Estimate Revisions: Four estimates for 2024 moved north in the past 60 days versus no southward revision, reflecting analysts’ confidence in the company. The Zacks Consensus Estimate for 2023 earnings has moved up slightly in the past 60 days.
Positive Earnings Surprise History: IQV has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in all the trailing four quarters, delivering an earnings surprise of 1.6%, on average.
Strong Growth Prospects: The Zacks Consensus Estimate for IQV’s 2024 earnings is pegged at $11.04, indicating 8.3% year-over-year growth. The stock’s long-term expected earnings per share growth rate is 8.7%.
Growth Factors: IQVIA’s combined offerings of research and development and commercial services have been helping it to develop trusted relationships, resulting in a diversified base of more than 10,000 clients in over 100 countries.
The company has a huge collection of healthcare information that encompasses more than one billion comprehensive, longitudinal, non-identified patient records across sales, prescription and promotional data, electronic medical records, medical claims, genomics and social media. This enormous treasure trove of information is a distinguishing asset and perhaps a big barrier to entry for competitors.
IQVIA has a consistent record of share repurchases. In 2022, 2021 and 2020, the company repurchased shares worth $1.17 billion, $406 million and $447 million, respectively. Such moves not only instill investors’ confidence but also positively impact earnings per share.
Other Stocks to Consider
Investors interested in the broader Zacks Business Service sector may consider the following other top-ranked stocks:
Gartner (IT - Free Report) : The Zacks Consensus Estimate for Gartner’s 2023 revenues indicates 7.9% growth from the year-ago figure. Its earnings are expected to decline 1.9% year over year. The company’s earnings beat the consensus estimate in each of the trailing four quarters, with the average surprise being 34.4%.
IT sports a Zacks Rank of 1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Broadridge Financial Solutions (BR - Free Report) : The Zacks Consensus Estimate for Broadridge’s fiscal 2024 revenues indicates 7.7% growth from the year-ago figure. Its earnings are expected to grow 10.1% year over year. The company beat the consensus estimate for earnings in three of the past four quarters and matched once, with the average surprise being 5.4%.
BR currently carries a Zacks Rank of 2.